ATE454394T1 - Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen - Google Patents

Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen

Info

Publication number
ATE454394T1
ATE454394T1 AT02746872T AT02746872T ATE454394T1 AT E454394 T1 ATE454394 T1 AT E454394T1 AT 02746872 T AT02746872 T AT 02746872T AT 02746872 T AT02746872 T AT 02746872T AT E454394 T1 ATE454394 T1 AT E454394T1
Authority
AT
Austria
Prior art keywords
eimeria
kda
merozoites
polypeptide
nucleic acid
Prior art date
Application number
AT02746872T
Other languages
English (en)
Inventor
David Witcombe
Nicholas Smith
Michael Wallach
Original Assignee
Abic Biolog Lab Ltd
Univ Sydney Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Biolog Lab Ltd, Univ Sydney Tech filed Critical Abic Biolog Lab Ltd
Application granted granted Critical
Publication of ATE454394T1 publication Critical patent/ATE454394T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT02746872T 2001-07-06 2002-07-03 Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen ATE454394T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30367001P 2001-07-06 2001-07-06
PCT/US2002/021237 WO2003004684A2 (en) 2001-07-06 2002-07-03 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES

Publications (1)

Publication Number Publication Date
ATE454394T1 true ATE454394T1 (de) 2010-01-15

Family

ID=23173154

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746872T ATE454394T1 (de) 2001-07-06 2002-07-03 Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen

Country Status (10)

Country Link
US (1) US7462707B1 (de)
EP (1) EP1478654B1 (de)
CN (1) CN100348608C (de)
AT (1) ATE454394T1 (de)
AU (1) AU2002316560B2 (de)
BR (1) BR0210850A (de)
DE (1) DE60235044D1 (de)
IL (2) IL159717A0 (de)
RU (1) RU2004103468A (de)
WO (1) WO2003004684A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0775746T3 (da) * 1995-07-03 2006-04-03 Akzo Nobel Nv Vaccine mod fjerkræcoccidiose
PL2066339T3 (pl) 2006-09-18 2015-02-27 Univ Arkansas Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
PT3097926T (pt) * 2007-11-01 2020-01-08 Univ Guelph Composições e métodos de potenciação das respostas imunitárias frente a eimeria
US20100150958A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. Methods and Compositions for Use of a Coccidiosis Vaccine
AR094791A1 (es) 2013-02-14 2015-08-26 Univ Arkansas Composiciones y métodos para mejorar las respuestas inmunes ante una infección por eimeria o para limitar una infección por eimeria
CN113041344B (zh) * 2021-03-19 2023-07-18 吉林大学 一种柔嫩艾美耳球虫的壳聚糖/纳米粒及制备方法
CN119605730B (zh) * 2024-11-27 2025-12-12 山东农业大学 一种提高雏鸡出壳体重和促进早期生长发育的方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135712A3 (de) 1983-08-19 1987-05-27 American Cyanamid Company Gegen Sporozoiten von Eimeria Spp. reaktive monoklonale Antikörper und Antigene
CA1340520C (en) 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US4639372A (en) 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
WO1990000403A1 (en) 1988-07-05 1990-01-25 Genex Corporation Genetically engineered coccidiosis vaccine
US5496550A (en) 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
CA1340838C (en) 1986-08-14 1999-12-07 Michael Wallach Coccidiosis vacine
ZA200400479B (en) 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use

Also Published As

Publication number Publication date
EP1478654A4 (de) 2005-03-30
AU2002316560B2 (en) 2008-05-01
EP1478654B1 (de) 2010-01-06
BR0210850A (pt) 2004-12-07
IL159717A (en) 2010-05-31
WO2003004684A2 (en) 2003-01-16
RU2004103468A (ru) 2005-04-20
DE60235044D1 (de) 2010-02-25
WO2003004684A3 (en) 2004-05-21
IL159717A0 (en) 2004-06-20
WO2003004684A9 (en) 2003-12-18
EP1478654A2 (de) 2004-11-24
US7462707B1 (en) 2008-12-09
CN1592751A (zh) 2005-03-09
CN100348608C (zh) 2007-11-14

Similar Documents

Publication Publication Date Title
Ridley et al. A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys
Etlinger et al. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum
Lillehoj et al. Embryo vaccination against Eimeria tenella and E. acervulina infections using recombinant proteins and cytokine adjuvants
Tian et al. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii
DE60235021D1 (de) Rekombinante, 56 bzw. 82 kda grosse antigene aus gametozyten von eimeria maxima codierende nukleinsäuren und ihre verwendungen
WO2003016354A3 (en) Recombinant anti-plasmodium falciparum antibodies
Arévalo-Herrera et al. Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein
Marussig et al. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
Barnwell et al. Plasmodium vivax: a glimpse into the unique and shared biology of the merozoite
ATE454394T1 (de) Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen
WO1997026911A1 (en) Malaria vaccine based upon the addition of a msa1 peptide
UY23445A1 (es) Procedimiento para la preparacion de vacunas contra la coccidiosis
US5217898A (en) Expression of the P. falciparum transmission-blocking antigen in yeast
HUP9802238A2 (hu) Fokozott immunizáló képességű módosított polipeptidek
Mehrizi et al. Immune responses elicited by co‐immunization of Plasmodium vivax and P. falciparum MSP‐1 using prime‐boost immunization strategies
US7749519B2 (en) Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax
Sheikh et al. Immunogenicity of a plasmid DNA vaccine encoding 42 kDa fragment of plasmodium vivax merozoite surface protein-1
Heidrich Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review
KR890000106A (ko) 원생성 기생충 예방용 백신
Good et al. Adapting immunity with subunit vaccines: case studies with group A Streptococcus and malaria
US20100119539A1 (en) Vaccine against malaria, based on the 200l subuniti of plasmodium vivax msp1 protein
CN100457780C (zh) 重组恶性疟原虫175kD红细胞结合抗原功能区蛋白及其制法和用途
CN100510080C (zh) 恶性疟原虫新的抗原候选基因PfMAg
Tonukari Theileria parva apical membrane antigen-1 (AMA-1) shares conserved sequences with apicomplexan homologs
Fang et al. The humoral immune responses elicited in mice by inoculations with a recombinant protein or DNA based on the circumsporozoite-protein gene of Plasmodium falciparum

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties